Clearmind Medicine releases update on intranasal MEAI formulation retention study

CMND•2026-07-16

Study update on intranasal MEAI formulation retention

Clearmind Medicine reported positive ex vivo mucoadhesion results for an intranasal MEAI formulation, showing higher nasal tissue retention than a standard solution.

Clearmind Medicine releases update on intranasal MEAI formulation retention study

Study update on intranasal MEAI formulation retention

Related News

US Stocks Snapshot-S&P 500, Nasdaq Open Lower as Chip Stocks Weaken

Trump Media unveils data feed for businesses tracking Truth Social posts

Shopify Inc <SHOP.O>: Wedbush Assumes Coverage With Outperform Rating; Target Price $155

Nasdaq trade halt continues PC.O reason not available at 09:45 AM

KT Corp announces Q3 2026 distribution of R$ 0.75 per unit for BRK1TCBDR007